Biocrates Life Sciences
Biocrates Life Sciences AG, developer of targeted metabolic phenotyping solutions, supports the discovery and validation of biomarkers for complex diseases.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| investor investor | €0.0 | round | |
* | N/A | Acquisition | |
| Total Funding | 000k | ||
| EUR | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | 2 % | (10 %) | 44 % | (11 %) | 14 % | 12 % | - |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | (33 %) | (72 %) | (34 %) | (9 %) | (15 %) | (21 %) | - |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (36 %) | (342 %) | (182 %) | (12 %) | (19 %) | (25 %) | - |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article, Dealroom estimates
Related Content
Biocrates is a company specializing in targeted metabolomics, providing ready-to-measure kits and services designed for quantitative, reproducible, and standardized mass spectrometry-based research. The company serves a diverse range of clients including academic researchers, clinical laboratories, and pharmaceutical companies. Operating in the biotechnology and healthcare market, Biocrates' business model revolves around the sale of metabolomics kits and the provision of related services. Revenue is generated through the direct sale of these kits and through service contracts for specialized metabolomics analysis. The company also engages in educational activities, offering webinars on topics such as nutrition, clinical metabolomics, and neurodegenerative diseases. By ensuring high-quality, reliable data, Biocrates supports scientific discoveries and advancements in personalized health.
Keywords: metabolomics, mass spectrometry, quantitative analysis, reproducible results, standardized methods, academic research, clinical laboratories, pharmaceutical companies, personalized health, biotechnology.